SANDOSTATIN LAR
Powder and solvent for suspension for injection, 10mg
RxActive license
Active substance (INN)
octreotide
Pharmaceutical form
Pharmaceutical formPowder and solvent for suspension for injection
Strength10mg
PackagingUkupno 1 bočica staklena sa 10mg praška za suspenziju za injekciju i 1 napunjeni injekcioni špric sa 2ml rastvarača u kartonskoj kutiji
ManufacturerNovartis Farmaceutica S.A., Spain
Therapeutic groupSystemic hormonal preparations (H01CB02)
Marketing authorization holder"NOVARTIS PHARMA SERVICES AG" DIO STRANOG DRUŠTVA PODGORICA
Authorization dateOctober 28, 2025
Analogs in Montenegro
6Other medicines with the same active substance
OKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 30mgOKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 10mgOKTREOTID TEVARx
Powder and solvent for prolonged-release suspension for injection, 20mgSANDOSTATINRx
Solution for injection/infusion, 0.1mg/mlSANDOSTATIN LARRx
Powder and solvent for suspension for injection, 20 mgSANDOSTATIN LARRx
Powder and solvent for suspension for injection, 30mgSource: CInMED register